spacer
spacer

PDBsum entry 5oy4

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Transferase PDB id
5oy4

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
350 a.a.
25 a.a.
24 a.a.
Ligands
SO4 ×4
B4K ×2
Waters ×6
PDB id:
5oy4
Name: Transferase
Title: Gsk3beta complex with n-(6-(3,4-dihydroxyphenyl)-1h-pyrazolo[3,4- b]pyridin-3-yl)acetamide
Structure: Glycogen synthase kinase-3 beta. Chain: a, b. Synonym: gsk-3 beta,serine/threonine-protein kinase gsk3b. Engineered: yes. Proto-oncogene frat1. Chain: x, y. Synonym: frequently rearranged in advanced t-cell lymphomas 1,frat-1. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: gsk3b. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Synthetic: yes. Organism_taxid: 9606
Resolution:
3.20Å     R-factor:   0.196     R-free:   0.229
Authors: B.D.Bax,M.A.Convery
Key ref: Z.A.Henley et al. (2017). From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome. ACS Med Chem Lett, 8, 1093-1098. PubMed id: 29057057
Date:
07-Sep-17     Release date:   01-Nov-17    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
P49841  (GSK3B_HUMAN) -  Glycogen synthase kinase-3 beta from Homo sapiens
Seq:
Struc:
420 a.a.
350 a.a.
Protein chain
Q92837  (FRAT1_HUMAN) -  Proto-oncogene FRAT1 from Homo sapiens
Seq:
Struc:
279 a.a.
25 a.a.
Protein chain
Q92837  (FRAT1_HUMAN) -  Proto-oncogene FRAT1 from Homo sapiens
Seq:
Struc:
279 a.a.
24 a.a.
Key:    Secondary structure

 Enzyme reactions 
   Enzyme class 1: Chains A, B: E.C.2.7.11.1  - non-specific serine/threonine protein kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
2. L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
L-seryl-[protein]
+ ATP
= O-phospho-L-seryl-[protein]
Bound ligand (Het Group name = B4K)
matches with 45.45% similarity
+ ADP
+ H(+)
L-threonyl-[protein]
+ ATP
= O-phospho-L-threonyl-[protein]
Bound ligand (Het Group name = B4K)
matches with 45.45% similarity
+ ADP
+ H(+)
   Enzyme class 2: Chains A, B: E.C.2.7.11.26  - [tau protein] kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[tau protein] + ATP = O-phospho-L-seryl-[tau protein] + ADP + H+
2. L-threonyl-[tau protein] + ATP = O-phospho-L-threonyl-[tau protein] + ADP + H+
L-seryl-[tau protein]
+ ATP
= O-phospho-L-seryl-[tau protein]
Bound ligand (Het Group name = B4K)
matches with 45.45% similarity
+ ADP
+ H(+)
L-threonyl-[tau protein]
+ ATP
= O-phospho-L-threonyl-[tau protein]
Bound ligand (Het Group name = B4K)
matches with 45.45% similarity
+ ADP
+ H(+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
ACS Med Chem Lett 8:1093-1098 (2017)
PubMed id: 29057057  
 
 
From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome.
Z.A.Henley, B.D.Bax, L.M.Inglesby, A.Champigny, S.Gaines, P.Faulder, J.Le, D.A.Thomas, Y.Washio, I.R.Baldwin.
 
  ABSTRACT  
 
Selective inhibitors of phosphoinositide 3-kinase delta are of interest for the treatment of inflammatory diseases. Initial optimization of a 3-substituted indazole hit compound targeting the kinase PIM1 focused on improving selectivity over GSK3β through consideration of differences in the ATP binding pockets. Continued kinase cross-screening showed PI3Kδ activity in a series of 4,6-disubstituted indazole compounds, and subsequent structure-activity relationship exploration led to the discovery of an indole-containing lead compound as a potent PI3Kδ inhibitor with selectivity over the other PI3K isoforms.
 

 

spacer

spacer